Dashenlin Pharmaceutical's controlling shareholder releases significant share pledge

Dashenlin Pharmaceutical Group announced on December 20, 2025, that its controlling shareholder, Mr. Ke Kangbao, released a pledge on 30,000,000 shares. This transaction, completed on December 18, 2025, represents 16.84% of his total holdings and 2.63% of the company's total share capital.

Following this release, Mr. Ke Kangbao's remaining pledged shares stand at 40,500,000, which is 22.73% of his total ownership and 3.56% of Dashenlin's total share capital.

Overall, the total pledged shares by the company's controlling shareholders and their concerted parties now amount to 89,822,320 shares, representing 12.71% of their collective holdings and 7.90% of the total share capital.